In addition, FLCN mutation analysis should be considered for patients who have familial cystic lung disease, familial pneumothorax, familial renal cancer, or any combination of spontaneous pneumothorax and kidney cancer (Menko et al, 2009). The gene discussed is FLCN; the disease is kidney cancer.